Newly released Internal Pfizer COVID-19 vaccine adverse event surveillance report reveals millions of adverse events, significant portion classified as serious.

As more and more Pfizer documents are being released, this particular one stands out as the most alarming to date. The 393-page Pfizer (BNT162B2) COVID-19 vaccine post-marketing surveillance report covers a six-month period from December 19, 2021, to June 18, 2022. The report includes over 10,000 different categories of adverse events

According to the report, nearly 5 million adverse events have been reported since the initiation of Pfizer's (BNT162B2) vaccine roll-out surveillance, with almost 1.6 million adverse events reported specifically within the timeframe covered by this six-month report.

Before I dive into the significant findings, it is important to provide explanations of certain terms within this report to enhance your understanding of the information you are reading and analyzing.

Post-marketing Data: This refers to monitoring the vaccine's safety and effectiveness after it has been distributed to the population. It aims to track any adverse events or side effects that occur in real-world conditions.

Spontaneous report: This term refers to adverse events or side effects that are reported voluntarily by healthcare professionals or citizens. These reports are often made to a vaccine side effect program such as the Vaccine Adverse Event Reporting System (VAERS) in the United States.

Non-interventional Study: It involves studies like cohort studies, where researchers observe a group of individuals over time. In this type of study, there is no active intervention or manipulation of variables by the researchers.

Interval or (I): In a statistical context, an interval refers to a specific range or period of time or value. So in this case the interval would be from December 19, 2021 to June 18, 2022.

Cumulative or (C): Cumulative, on the other hand, involves the accumulation or aggregation of values over time or across multiple intervals. So in this case it would be the number of reports received since the vaccine roll-out surveillance began up to June 21, 2022, when this report was finalized.

Now that we have addressed that, let's examine some of the discoveries outlined in the report.

Let's look into some of the notable serious adverse events reported and the associated experiences. Firstly, focusing on the Cardiac disorders section of the report, the findings reveal that within the timeframe covered by this report, 391 individuals suffered from cardiac arrest, while since the beginning of Pfizer's vaccine roll-out monitoring, a total of 1,516 cases of cardiac arrest have been recorded.

Another observation relates to atrial fibrillation, which is characterized as an irregular and often rapid heart rhythm (arrhythmia) that can potentially result in blood clots within the heart. Atrial fibrillation increases the risk of stroke, heart failure, and other heart-related complications. As per this report, 1,142 individuals experienced atrial fibrillation, and throughout the entire surveillance period, a total of 3,554 cases were documented.

Lets examine the Cardiac failure section. The report categorizes cardiac failure into four distinct groups, and within the span of this six-month report alone, a total of 737 instances of cardiac failure were documented. Cumulatively, since the commencement of the vaccine roll-out monitoring, there have been 2,502 reported cases of cardiac failure types across all four categories.

The cumulative data reveals a significant number of cardiac-related disorders, with a total of 126,993 cases reported. Among them, 82,911 cases were classified as serious. This stark contrast indicates that the number of serious cardiac-related disorders outweighs those categorized as non-serious. This observation alone should be ringing alarm bells.

One particularly significant and interesting finding in this report concerns the COVID-19 virus itself. According to Pfizer's own report, there were a cumulative total of 72,695 reports of serious COVID-19 cases among vaccinated individuals, in contrast to 3,317 reports categorized as non-serious. This data indicates that, based on their own findings, a higher number of vaccinated individuals experienced severe episodes of COVID-19 compared to nonserious cases.

If you would like to review the report for yourself, you can do so at the link provided below. There is certainly a wealth of information in this report. I have briefly glanced over some of the categories, and the results do not appear favorable for Pfizer. It is notable that there are often more reports of serious adverse events than non-serious ones.

https://drive.google.com/file/d/1Dd76YNVHfTp8u-e5LOnLzxQYvGIie5W0/view?usp=sharing